Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Korean"

44 News Found

BPL Medical Technologies brings next-gen Korean ultrasound to India
Medical Device | November 21, 2025

BPL Medical Technologies brings next-gen Korean ultrasound to India

The X CUBE 50 integrates ALPINION’s advanced X+ Architecture


DKSH Technology acquires Korean life science firm MDxK
Supply Chain | March 31, 2025

DKSH Technology acquires Korean life science firm MDxK

The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market


Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery
News | January 09, 2025

Evonik partners with South Korean ST Pharm to increase its offerings for RNA and nucleic acid delivery

Increases speed to market for drug developers working on nucleic acid therapeutics


Surging demand for Korean pharma in 2023 ahead of CPHI Korea
News | August 08, 2023

Surging demand for Korean pharma in 2023 ahead of CPHI Korea

Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings


Samsung Engineering wins work contract from Sartorius for Korean plant
Biotech | December 09, 2022

Samsung Engineering wins work contract from Sartorius for Korean plant

The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters


IOL receives Korean FDA approval
Drug Approval | October 14, 2021

IOL receives Korean FDA approval

The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead


Zydus Wellness FY26 revenue climbs to Rs. 39.4 billion
Healthcare | May 19, 2026

Zydus Wellness FY26 revenue climbs to Rs. 39.4 billion

Growth driven by strong performance across Sugar Free, RiteBite Max Protein, Everyuth, Glucon-D and Nutralite portfolios


SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer
Clinical Trials | May 19, 2026

SN Bioscience doses first patient in global trial of experimental drug for aggressive lung cancer

The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients


Amrutanjan Healthcare expands portfolio in pain management
News | May 18, 2026

Amrutanjan Healthcare expands portfolio in pain management

Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil


ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
Healthcare | April 17, 2026

ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific

American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden